|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 08, 2018 ) Male infertility is a widespread disorder, which refers to a male's inability to impregnate his fertile female partner. It occurs due to deficiencies in semen, poor sperm quality, lower hormonal support, and abnormal ejaculation.
Publisher's analysts forecast the global male infertility market to grow at a CAGR of 5.68% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-male-infertility-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global male infertility market for 2017-2021. To calculate the market size, the report considers the male infertility treatment, which includes products (drugs) and services.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Male Infertility Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- ASKA Pharmaceutical
- Halotech DNA
- Merck Serono
- Zydus Cadila Healthcare
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001692677/sample .
Other prominent vendors
- AbbVie
- Apricus Biosciences
- Aytu BioScience
- Bristol-Myers Squibb
- CooperSurgical
- Medical Electronic Systems
- OvaScience
- MedITEX
- Xytex Cryo International
Market driver
- Higher occurrence of diabetes among men
- For a full, detailed list, view our report
Market challenge
- High cost associated with treatment of male infertility
- For a full, detailed list, view our report
Market trend
- Monetary growth among consumers
- For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001692677/buying .
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
